Report
$5.2 million raised to accelerate work on Australian Covid-19 vaccine
MEDIA RELEASE August 2021 Australian biotechnology company Sementis Limited has raised more than $5.2 million to accelerate...
-
-
Report
Australia accelerates new COVID-19 vaccine to fight mutant strains
MEDIA RELEASE May 2021 A leading South Australian immunologist has been awarded $3 million from the Federal Government...
-
Report
New Director to Support COVID Vaccine Development at Sementis
April 2021 Adelaide-based Australian biotechnology company Sementis has appointed internationally-renowned Dr Anna...
-
Report
NHMRC Ideas Grant to support the development UniSA-Sementis peanut allergy vaccine
MEDIA RELEASE December 2020 Researchers at UniSA and Sementis are moving a step closer to developing a vaccine...
-
Report
UniSA helping to bring cheaper, needle-free, vaccines to the world
MEDIA RELEASE November 2018 In an international collaboration between Sementis and Enesi Pharma, Sementis...